CCN2 and amyotrophic lateral sclerosis: An in vitro study using Schwann cells as a source of CTFG/CCN2 showed that this molecule inhibits oligodendrocyte myelination and promotes astrocyte reactivity supporting the hypothesis that CTGF/CCN2 may specifically impair oligodendrocyte maturation and inhibit axon myelination in ALS disease [111].